Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Basal ganglia neurotoxins.

R L Albin1

  • 1Department of Neurology, University of Michigan, Ann Arbor, USA.

Neurologic Clinics
|June 29, 2000
PubMed
Summary

This review covers basal ganglia neurotoxins, their effects, and mechanisms. Most toxins inhibit mitochondrial function, damaging the pallidum and putamen, with MPTP targeting dopaminergic neurons.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Body Composition, Falls, and Freezing of Gait in Parkinson's Disease: Gender-Specific Effects.

The Journal of frailty & aging·2024
Same author

Correction to: Noradrenergic cardiac denervation is associated with gait velocity in Parkinson disease: a dual ligand PET study.

European journal of nuclear medicine and molecular imaging·2024
Same author

Noradrenergic cardiac denervation is associated with gait velocity in Parkinson disease: a dual ligand PET study.

European journal of nuclear medicine and molecular imaging·2024
Same author

Cardiac sympathetic denervation and anxiety in Parkinson disease.

Parkinsonism & related disorders·2024
Same author

Predicting Progression from Normal to MCI and from MCI to AD Using Clinical Variables in the National Alzheimer's Coordinating Center Uniform Data Set Version 3: Application of Machine Learning Models and a Probability Calculator.

The journal of prevention of Alzheimer's disease·2023
Same author

Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease.

Parkinsonism & related disorders·2016

Area of Science:

  • Neuroscience
  • Toxicology
  • Pathology

Background:

  • Basal ganglia neurotoxins pose significant health risks.
  • Understanding their mechanisms is crucial for diagnosis and treatment.
  • Various chemical agents are known to affect basal ganglia function.

Purpose of the Study:

  • To review the epidemiology, clinical features, pathology, and mechanisms of action of basal ganglia neurotoxins.
  • To discuss specific neurotoxins including manganese, cyanide, and MPTP.
  • To elucidate the common pathways of neurodegeneration induced by these toxins.

Main Methods:

  • Literature review of epidemiological, clinical, and pathological studies.
  • Analysis of proposed mechanisms of action for various neurotoxins.
  • Synthesis of information on toxin-induced basal ganglia damage.

Main Results:

  • Manganese, cyanide, hydrogen sulfide, methanol, carbon monoxide, 3-nitropropionic acid, MPTP, and annonaceae alkaloids are identified as basal ganglia neurotoxins.
  • The primary mechanism involves inhibition of mitochondrial function, leading to pallidal and putaminal destruction.
  • MPTP exhibits selective toxicity to dopaminergic neurons due to specific metabolite uptake.

Conclusions:

  • Mitochondrial dysfunction is a probable common mechanism for most basal ganglia neurotoxins.
  • The selective vulnerability of the putamen and pallidum remains an area for further investigation.
  • Further research is needed to understand the selective neurotoxicity of agents like MPTP.

Related Experiment Videos